1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FF8561F2B313ED2300258A3B00079ED1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew!SearchView&Query=(Field ph=T and FIELD+publishdate+>=+1/11/2007)+AND+(the)+and+(field+ItemCatalog=DB)&SearchWV=1&SearchFuzzy=1&SearchOrder=1&Start=1&Count=10
18
19SearchView&Query=(Field%20ph=T%20and%20FIELD%20publishdate%20%3E=%201/11/2007)%20AND%20(the)%20and%20(field%20ItemCatalog=DB)&SearchWV=1&SearchFuzzy=1&SearchOrder=1&Start=1&Count=10
2034.204.172.188
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Digital Technology Consortium Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Pharma and Medical Device Quality New Product Planning Medical Affairs Pharmaceutical Launch Market Research Competitive Intelligence

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Managed Care Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda Blog
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos Blog
Database Member Home RAS Member Home

Search Results

Results 1 - 10 of 603 Total Hits, .

    |    
DB Image

Cariprazine: The Market Landscape for a Second-Generation Atypical AntipsychoticDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

STUDY OVERVIEW This short case study examines cariprazine, a second-generation atypical antipsychotic therapy developed by Forest Laboratories and Gedeon Richter... (ID 5302)
Companies Profiled: Forest Laboratories, Gedeon Richter Ltd.

$200.00

DB Image

Using Disease Management Systems to Thwart Generic Competitors: A Case StudyDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Companies seeking to develop strategies and tactics that enhance the post-patent success of products can learn from products that maintained market share in the face of generic competition... (ID 4246)
Companies Profiled: Novartis

$574.95

DB Image

Library Services Staffing MetricsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Library Services Staffing Metrics" STUDY OVERVIEW Company libraries provide valuabl... (ID 5329)
Companies Profiled: Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim, Eisai, Eli Lilly, more ...

$500.00

Download Free Excerpt

DB Image

Zyprexa: Portrait of a Successful Lifecycle for an Atypical AntipsychoticDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

STUDY OVERVIEW This 4-page case study examines Zyprexa, the third atypical antipsychotic therapy when it was approved in 1996 by the FDA... (ID 5303)
Companies Profiled: Eli Lilly

$200.00

DB Image

Assessing Gamification Technologies and Approaches for the Pharma SectorDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

STUDY OVERVIEW The use of game elements to capture consumer's attention makes sense for business functions such as marketing or human resources... (ID 5294)
Companies Profiled: Eli Lilly, Genentech, Boehringer Ingelheim

$500.00

DB Image

Vectibix Case Study: How Amgen Collaborated with the Colon Cancer Alliance to Ensure Market EducationDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

This case study reviews how Amgen interacted with a leading patient advocacy group to support Vectibix, a colorectal cancer treatment... (ID 5067)
Companies Profiled: Amgen

$1000.00

Download Free Excerpt

DB Image

Slentrol Case Study: Using Integrated PR Tactics to Support a Product LaunchDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-Members: To download a complimentary excerpt of this study, please click here... (ID 5014)
Companies Profiled: Pfizer Animal Health

$1000.00

Download Free Excerpt

DB Image

Corporate Library Services in the Biopharmaceutical Industry: Library Profile and ManagementDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Corporate Library Services in the Biopharmaceutical Industry: Library Profile and Man... (ID 5738)
Companies Profiled: Alkermes, Amgen, ANA (Association of National Advertisers), Astellas, more ...

$1400.00

Download Free Excerpt

DB Image

ULTOMIRIS Case Analysis: Summoning the Right Sales Resources to Support a New Blockbuster’s LaunchDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "ULTOMIRIS Case Analysis: Summoning the Right Sales Resources to Support a New Blockbu... (ID 5682)
Companies Profiled: Alexion Pharmaceuticals

$900.00

Download Free Excerpt

DB Image

MSL Engagements Related to On-Label DataDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "MSL Engagements Related to On-Label Data" STUDY OVERVIEW As the role of Medical Sci... (ID 5626)
Companies Profiled: Eisai, Puma Biotechnology, AstraZeneca, B. Braun, more ...

$1000.00

Download Free Excerpt

Search tips...